USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

Search

Ashland Global Holdings Inc

Suletud

SektorToorained

57.74 -2.65

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

57.03

Max

59.09

Põhinäitajad

By Trading Economics

Sissetulek

-181M

-165M

Müük

-117M

405M

Aktsiakasum

0.28

Dividenditootlus

2.73

Kasumimarginaal

-40.741

Töötajad

3,200

EBITDA

-223M

-140M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+31.94% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.73%

2.80%

Järgmine tulemuste avaldamine

29. apr 2025

Järgmine dividendimakse kuupäev

13. juuni 2025

Järgmine aktsia dividendi kuupäev (ex-date)

30. mai 2025

Turustatistika

By TradingEconomics

Turukapital

2.8B

Eelmine avamishind

60.39

Eelmine sulgemishind

57.74

Uudiste sentiment

By Acuity

50%

50%

76 / 170 Pingereas Basic materials

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

Ashland Global Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. märts 2025, 11:00 UTC

Omandamised, ülevõtmised, äriostud

Ashland Completes Sale of Avoca Business to Mane

28. jaan 2025, 22:05 UTC

Tulu

Ashland 1Q Adj EPS 28c >ASH

28. jaan 2025, 22:04 UTC

Tulu

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

28. jaan 2025, 22:04 UTC

Tulu

Ashland 1Q Sales $405M >ASH

28. jaan 2025, 22:04 UTC

Tulu

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

28. jaan 2025, 22:03 UTC

Tulu

Ashland 1Q Loss/Shr $3.50 >ASH

6. nov 2024, 22:07 UTC

Tulu

Ashland 4Q EPS 39c >ASH

6. nov 2024, 22:07 UTC

Tulu

Ashland 4Q Sales $522M >ASH

6. nov 2024, 22:07 UTC

Tulu

Ashland Sees FY25 Sales $1.90B-$2.05B >ASH

3. sept 2024, 11:00 UTC

Omandamised, ülevõtmised, äriostud

Ashland Completes Sale of Nutraceuticals Business to Affil of Turnspire Capital Partners >ASH

6. aug 2024, 21:04 UTC

Tulu

Ashland Sees FY Sales $2.1B >ASH

6. aug 2024, 21:03 UTC

Tulu

Ashland Sees 4Q Sales $530M-$540M >ASH

6. aug 2024, 21:03 UTC

Tulu

Ashland 3Q Adj EPS $1.49 >ASH

6. aug 2024, 21:02 UTC

Tulu

Ashland 3Q Sales $544M >ASH

6. aug 2024, 21:02 UTC

Tulu

Ashland 3Q Cont Ops EPS 60c >ASH

6. aug 2024, 21:02 UTC

Tulu

Ashland 3Q EPS 12c >ASH

6. aug 2024, 21:02 UTC

Tulu

Ashland Issues Outlook for 4Q and Full-Yr Fiscal 2024

7. mai 2024, 11:01 UTC

Omandamised, ülevõtmised, äriostud

Ashland: Transaction Is Expected to Close in 3Q >ASH

7. mai 2024, 10:59 UTC

Omandamised, ülevõtmised, äriostud

Ashland Signs Definitive Agreement to Sell Nutraceuticals Business to Turnspire Capital Partners >ASH

Võrdlus sarnastega

Hinnamuutus

Ashland Global Holdings Inc Prognoos

Hinnasiht

By TipRanks

31.94% tõus

12 kuu keskmine prognoos

Keskmine 77.86 USD  31.94%

Kõrge 93 USD

Madal 68 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Ashland Global Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

9 ratings

6

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

56.33 / 59.72Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Keskpikk perspektiiv

Weak Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

76 / 170 Pingereas Toorained

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Ashland Global Holdings Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.